Rosenblatt lowered the firm’s price target on Arteris to $15 from $21 and keeps a Buy rating on the shares. The company reported earnings upside in Q3 but offered a disappointing Q4 outlook on weaker China licensing, the analyst tells investors in a research note. The firm dropped the price target to reflect lower 2025 sales estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AIP:
- Arteris Announces Financial Results for the Third Quarter 2023 and Fourth Quarter and Full Year 2023 Guidance
- Arteris IP awarded ISO 9001 certification for semiconductor system IP system
- Arteris Awarded ISO 9001 Certification for Semiconductor System IP Quality Management System
- Semidynamics and Arteris Partner To Accelerate AI RISC-V System-on-Chip Development
- Arteris IP, Semidynamics partner to accelerate AI RISC-V
